207 related articles for article (PubMed ID: 33966822)
1. Microfluidic platform for synthesis and optimization of chitosan-coated magnetic nanoparticles in cisplatin delivery.
Siavashy S; Soltani M; Ghorbani-Bidkorbeh F; Fallah N; Farnam G; Mortazavi SA; Shirazi FH; Tehrani MHH; Hamedi MH
Carbohydr Polym; 2021 Aug; 265():118027. PubMed ID: 33966822
[TBL] [Abstract][Full Text] [Related]
2. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
[TBL] [Abstract][Full Text] [Related]
3. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells.
Javid A; Ahmadian S; Saboury AA; Kalantar SM; Rezaei-Zarchi S
Chem Biol Drug Des; 2013 Sep; 82(3):296-306. PubMed ID: 23594157
[TBL] [Abstract][Full Text] [Related]
4. ROS-Responsive Chitosan Coated Magnetic Iron Oxide Nanoparticles as Potential Vehicles for Targeted Drug Delivery in Cancer Therapy.
Ayyanaar S; Balachandran C; Bhaskar RC; Kesavan MP; Aoki S; Raja RP; Rajesh J; Webster TJ; Rajagopal G
Int J Nanomedicine; 2020; 15():3333-3346. PubMed ID: 32494133
[TBL] [Abstract][Full Text] [Related]
5. Analytical characteristics and application of novel chitosan coated magnetic nanoparticles as an efficient drug delivery system for ciprofloxacin. Enhanced drug release kinetics by low-frequency ultrasounds.
Kariminia S; Shamsipur A; Shamsipur M
J Pharm Biomed Anal; 2016 Sep; 129():450-457. PubMed ID: 27497305
[TBL] [Abstract][Full Text] [Related]
6. Preparation and Evaluation of pH Sensitive Novel Anticancer Drug Carrier Based on Magnetic Chitosan Quartets.
Danafar H; Asadi F; Sharafi A; Manjili HK
Drug Res (Stuttg); 2019 Sep; 69(9):496-504. PubMed ID: 30912092
[TBL] [Abstract][Full Text] [Related]
7. Microfluidic Fabrication of Structure-Controlled Chitosan Microcapsules via Interfacial Cross-Linking of Droplet Templates.
Mu XT; Li Y; Ju XJ; Yang XL; Xie R; Wang W; Liu Z; Chu LY
ACS Appl Mater Interfaces; 2020 Dec; 12(51):57514-57525. PubMed ID: 33301686
[TBL] [Abstract][Full Text] [Related]
8. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
9. pH-controlled sunitinib anticancer release from magnetic chitosan nanoparticles crosslinked with κ-carrageenan.
Karimi MH; Mahdavinia GR; Massoumi B
Mater Sci Eng C Mater Biol Appl; 2018 Oct; 91():705-714. PubMed ID: 30033305
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin loaded magnetic Fe3O4/carboxymethylchitosan nanoparticles as tumor-targeted drug delivery system: Synthesis and in vitro characterization.
Li G; Cao L; Zhou Z; Chen Z; Huang Y; Zhao Y
Colloids Surf B Biointerfaces; 2015 Apr; 128():379-388. PubMed ID: 25779605
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-conjugated core-shell magnetite nanoparticles as dual-targeting carriers for anticancer drug delivery.
Sadighian S; Rostamizadeh K; Hosseini-Monfared H; Hamidi M
Colloids Surf B Biointerfaces; 2014 May; 117():406-13. PubMed ID: 24675279
[TBL] [Abstract][Full Text] [Related]
12. The enzyme-sensitive release of prodigiosin grafted β-cyclodextrin and chitosan magnetic nanoparticles as an anticancer drug delivery system: Synthesis, characterization and cytotoxicity studies.
Rastegari B; Karbalaei-Heidari HR; Zeinali S; Sheardown H
Colloids Surf B Biointerfaces; 2017 Oct; 158():589-601. PubMed ID: 28750341
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin prodrug conjugated Fe
Song H; Quan F; Yu Z; Zheng M; Ma Y; Xiao H; Ding F
J Mater Chem B; 2019 Jan; 7(3):433-442. PubMed ID: 32254730
[TBL] [Abstract][Full Text] [Related]
14. 5-Fluorouracil monodispersed chitosan microspheres: Microfluidic chip fabrication with crosslinking, characterization, drug release and anticancer activity.
He T; Wang W; Chen B; Wang J; Liang Q; Chen B
Carbohydr Polym; 2020 May; 236():116094. PubMed ID: 32172896
[TBL] [Abstract][Full Text] [Related]
15. Development of electrosprayed artesunate-loaded core-shell nanoparticles.
Ho HN; Laidmäe I; Kogermann K; Lust A; Meos A; Nguyen CN; Heinämäki J
Drug Dev Ind Pharm; 2017 Jul; 43(7):1134-1142. PubMed ID: 28277847
[TBL] [Abstract][Full Text] [Related]
16. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
[TBL] [Abstract][Full Text] [Related]
17. Layer-by-layer nanoparticle platform for cancer active targeting.
Suh MS; Shen J; Kuhn LT; Burgess DJ
Int J Pharm; 2017 Jan; 517(1-2):58-66. PubMed ID: 27923697
[TBL] [Abstract][Full Text] [Related]
18. Chitosan coated polylactic acid nanoparticle-mediated combinatorial delivery of cisplatin and siRNA/Plasmid DNA chemosensitizes cisplatin-resistant human ovarian cancer cells.
Babu A; Wang Q; Muralidharan R; Shanker M; Munshi A; Ramesh R
Mol Pharm; 2014 Aug; 11(8):2720-33. PubMed ID: 24922589
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel N-vinylpyrrolidone/acrylic acid nanoparticles as drug delivery carriers of cisplatin to cancer cells.
Pornpitchanarong C; Rojanarata T; Opanasopit P; Ngawhirunpat T; Patrojanasophon P
Colloids Surf B Biointerfaces; 2020 Jan; 185():110566. PubMed ID: 31655265
[TBL] [Abstract][Full Text] [Related]
20. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
